WFDC2 and ovarian cancer: Some studies have shown that HE4 is expressed at low levels in normal ovarian tissue but is more commonly expressed in malignant ovarian tumors, especially serous adenocarcinoma, while there is no significant increase in benign ovarian lesions (12–14).